Literature DB >> 22245598

The use of back-up units to enhance the safety of unrelated donor cord blood transplantation.

Doris M Ponce1, Marissa Lubin, Anne Marie Gonzales, Courtney Byam, Deborah Wells, Rosanna Ferrante, Glenn Heller, Sergio Giralt, Esperanza B Papadopoulos, Nancy A Kernan, Andromachi Scaradavou, Juliet N Barker.   

Abstract

The inability to obtain additional stem cells is a disadvantage of unrelated donor cord blood transplantation (CBT). Moreover, in the event of problems with unit shipment, compromised unit quality, thaw mishaps, or graft failure, the time to secure a back-up graft could be unacceptable. Emergent shipment of 1 to 2 back-up units that have been previously typed and reserved could overcome this limitation. However, the advantages of this approach are not established. Therefore, we present our use of back-up units over a 5.5-year period. Six of 121 CBT recipients (5%) required back-up unit infusion. Indications included shipment mishaps (n = 2), poor unit viability (n = 2), significant infusion reaction (n = 1), and graft failure (n = 1). Lack of back-up units would have caused transplantation delay or infusion of inferior-quality units. Five of the 6 patients achieved sustained donor engraftment. We demonstrate that back-up units are emergently required in a significant minority of patients, supporting the incorporation of at least 1 back-up unit in cord blood (CB) selection algorithms to enhance CBT safety.
Copyright © 2012 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22245598      PMCID: PMC3303962          DOI: 10.1016/j.bbmt.2011.12.588

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  16 in total

1.  Issues in the quality of umbilical cord blood stem cells for transplantation.

Authors:  Jeffrey McCullough; David McKenna; Diane Kadidlo; Therese Schierman; John Wagner
Journal:  Transfusion       Date:  2005-06       Impact factor: 3.157

2.  HLA mismatch direction in cord blood transplantation: impact on outcome and implications for cord blood unit selection.

Authors:  Cladd E Stevens; Carmelita Carrier; Carol Carpenter; Dorothy Sung; Andromachi Scaradavou
Journal:  Blood       Date:  2011-07-12       Impact factor: 22.113

3.  Assessment of cord blood unit characteristics on the day of transplant: comparison with data issued by cord blood banks.

Authors:  Eric Wagner; Michel Duval; Jean-Hugues Dalle; Hugo Morin; Sonia Bizier; Josette Champagne; Martin A Champagne
Journal:  Transfusion       Date:  2006-07       Impact factor: 3.157

4.  Cord blood units with low CD34+ cell viability have a low probability of engraftment after double unit transplantation.

Authors:  Andromachi Scaradavou; Katherine M Smith; Rebecca Hawke; Allison Schaible; Michelle Abboud; Nancy A Kernan; James W Young; Juliet N Barker
Journal:  Biol Blood Marrow Transplant       Date:  2009-11-22       Impact factor: 5.742

5.  Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units.

Authors:  Michael R Verneris; Claudio G Brunstein; Juliet Barker; Margaret L MacMillan; Todd DeFor; David H McKenna; Michael J Burke; Bruce R Blazar; Jeffrey S Miller; Philip B McGlave; Daniel J Weisdorf; John E Wagner
Journal:  Blood       Date:  2009-08-25       Impact factor: 22.113

6.  Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy.

Authors:  Juliet N Barker; Daniel J Weisdorf; Todd E DeFor; Bruce R Blazar; Philip B McGlave; Jeffrey S Miller; Catherine M Verfaillie; John E Wagner
Journal:  Blood       Date:  2004-10-05       Impact factor: 22.113

7.  A "no-wash" albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infusion reactions.

Authors:  Juliet N Barker; Michelle Abboud; Robert D Rice; Rebecca Hawke; Allison Schaible; Glenn Heller; Vincent La Russa; Andromachi Scaradavou
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-25       Impact factor: 5.742

8.  Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.

Authors:  Claudio G Brunstein; Juliet N Barker; Daniel J Weisdorf; Todd E DeFor; Jeffrey S Miller; Bruce R Blazar; Philip B McGlave; John E Wagner
Journal:  Blood       Date:  2007-06-14       Impact factor: 22.113

9.  Mislabeled units of umbilical cord blood detected by a quality assurance program at the transplantation center.

Authors:  Jeffrey McCullough; David McKenna; Diane Kadidlo; David Maurer; Harriett J Noreen; Kathy French; Claudio Brunstein; John E Wagner
Journal:  Blood       Date:  2009-06-01       Impact factor: 22.113

10.  Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation.

Authors:  Celso A Rodrigues; Guillermo Sanz; Claudio G Brunstein; Jaime Sanz; John E Wagner; Marc Renaud; Marcos de Lima; Mitchell S Cairo; Sabine Fürst; Bernard Rio; Christopher Dalley; Enric Carreras; Jean-Luc Harousseau; Mohamad Mohty; Denis Taveira; Peter Dreger; Anna Sureda; Eliane Gluckman; Vanderson Rocha
Journal:  J Clin Oncol       Date:  2008-12-08       Impact factor: 44.544

View more
  4 in total

1.  Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice.

Authors:  Duncan Purtill; Katherine Smith; Sean Devlin; Richard Meagher; Joann Tonon; Marissa Lubin; Doris M Ponce; Sergio Giralt; Nancy A Kernan; Andromachi Scaradavou; Cladd E Stevens; Juliet N Barker
Journal:  Blood       Date:  2014-09-02       Impact factor: 22.113

Review 2.  Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.

Authors:  Juliet N Barker; Joanne Kurtzberg; Karen Ballen; Michael Boo; Claudio Brunstein; Corey Cutler; Mitchell Horwitz; Filippo Milano; Amanda Olson; Stephen Spellman; John E Wagner; Colleen Delaney; Elizabeth Shpall
Journal:  Biol Blood Marrow Transplant       Date:  2017-03-06       Impact factor: 5.742

3.  Donor-recipient allele-level HLA matching of unrelated cord blood units reveals high degrees of mismatch and alters graft selection.

Authors:  P B Dahi; D M Ponce; S Devlin; K L Evans; M Lubin; A M Gonzales; C Byam; M Sideroff; D Wells; S Giralt; N A Kernan; A Scaradavou; J N Barker
Journal:  Bone Marrow Transplant       Date:  2014-07-07       Impact factor: 5.483

4.  Analysis of the CD34+ cell to total nucleated cell content ratio of 619 transplanted and back-up cord blood units.

Authors:  Ioannis Politikos; Christopher M Mazis; Kristine A Naputo; Kelcey Skinner; Melissa Nhaissi; Eric Davis; Andromachi Scaradavou; Juliet N Barker
Journal:  Bone Marrow Transplant       Date:  2020-08-29       Impact factor: 5.483

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.